PEDIATRIC ANTIBIOTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 to 2030)

Antibiotics are used to treat or prevent some types of bacterial infection. Antibiotics work by killing bacteria or preventing them from reproducing and spreading. Antibiotics are the most commonly prescribed drugs in children and have the potential to save the lives of patients with severe bacterial infections such as Non-Specific Upper Respiratory Tract Infections, Urinary Tract Infections etc. They are taken orally and come in the form of tablets, liquid suspension, and capsules. Antibiotics are also administered through the intravenous route. Antibiotics are available in the form of ointments, creams, lotions, etc. for topical administration.

Market Dynamics

Key players operating in the global pediatric antibiotics market are focusing on adoption of growth strategies such as product approval, which is expected to drive market growth during the forecast period. For instance, in January 2020, Merck a leading global biopharmaceutical company known as MSD outside of the U.S. and Canada, announced that the U.S. Food and Drug Administration (FDA) had approved a New Drug Application (NDA) for DIFICID (fidaxomicin) for oral suspension, and a supplemental New Drug Application (sNDA) for DIFICID tablets for the treatment of Clostridioides (formerly Clostridium) difficile-associated diarrhea (CDAD) in children aged six months and older. Moreover, increasing demand of pediatric antibiotics is expected to propel market growth over the forecast period. For instance, in 2021, United Nations International Children's Emergency Fund (UNICEF) delivered 31.6 million antibiotic treatments to children under one year of age in 54 countries.

 Key features of the study:

• This report provides in-depth analysis of the global pediatric antibiotics market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pediatric antibiotics market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
• Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Inc,  Pfizer Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Abbott., DAIICHI SANKYO COMPANY, LIMITED, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA, GlaxoSmithKline Plc., Hikma Pharmaceuticals PLC, Cipla Inc., Glenmark Pharmaceuticals, and Torrent Pharmaceuticals Ltd. Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pediatric antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric antibiotics market.

Detailed Segmentation:

• Global Pediatric antibiotics Market, By Infection :
  • Acute Sinusitis
  • Acute Otitis Media
  • Non-Specific Upper Respiratory Tract Infections
  • Urinary Tract Infections
  • Others
• Global Pediatric antibiotics Market, By Route of Administration :
  • Oral
  • Topical
  • Intravenous
  • Others
• Global Pediatric antibiotics Market, By Distribution Channel :
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
• Global Pediatric antibiotics Market, By Region:

• • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Johnson & Johnson.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Astellas Pharma, Inc,
  • Pfizer Inc
  • Novartis AG
  •  Bayer AG
  •  Bristol-Myers Squibb Company
  •  Abbott
  •  DAIICHI SANKYO COMPANY, LIMITED
  • Dr. Reddy’s Laboratories Ltd
  • Teva Pharmaceuticals USA, Inc
  •  Aurobindo Pharma USA
  • GlaxoSmithKline Plc
  • Hikma Pharmaceuticals PLC
  •  Cipla Inc
  •  Glenmark Pharmaceuticals
  • Torrent Pharmaceuticals Ltd., etc.

“*” marked represents similar segmentation in other categories in the respective section.